Vir Biotechnology, Inc. (VIR)
USD 6.16
(1.32%)
USD 6.16
(1.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -684.3 Million USD | -179.35% |
| 2022 | 833.06 Million USD | 200.86% |
| 2021 | 276.89 Million USD | 193.24% |
| 2020 | -296.98 Million USD | -66.86% |
| 2019 | -177.97 Million USD | -49.95% |
| 2018 | -118.69 Million USD | -45.64% |
| 2017 | -81.49 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -129.36 Million USD | -146.5% |
| 2024 Q3 | -218.59 Million USD | -68.97% |
| 2024 Q1 | -52.48 Million USD | 55.19% |
| 2023 Q2 | -215.18 Million USD | -50.09% |
| 2023 FY | -661 Million USD | -179.35% |
| 2023 Q4 | -117.11 Million USD | 37.28% |
| 2023 Q3 | -186.73 Million USD | 13.22% |
| 2023 Q1 | -143.37 Million USD | 4.74% |
| 2022 Q3 | 194.96 Million USD | 186.57% |
| 2022 Q2 | -225.22 Million USD | -122.22% |
| 2022 Q1 | 1.01 Billion USD | 77.32% |
| 2022 FY | 833.06 Million USD | 200.86% |
| 2022 Q4 | -150.5 Million USD | -177.19% |
| 2021 FY | 276.89 Million USD | 193.24% |
| 2021 Q4 | 571.75 Million USD | 1171.0% |
| 2021 Q3 | -53.38 Million USD | -187.49% |
| 2021 Q2 | 61.01 Million USD | 138.46% |
| 2021 Q1 | -158.63 Million USD | -46.34% |
| 2020 Q3 | -87.61 Million USD | -201.59% |
| 2020 Q2 | -29.05 Million USD | 59.6% |
| 2020 FY | -296.98 Million USD | -66.86% |
| 2020 Q1 | -71.91 Million USD | -12.78% |
| 2020 Q4 | -108.4 Million USD | -23.73% |
| 2019 Q3 | -47.68 Million USD | -33.3% |
| 2019 FY | -177.97 Million USD | -49.95% |
| 2019 Q1 | -30.77 Million USD | -14.83% |
| 2019 Q4 | -63.75 Million USD | -33.72% |
| 2019 Q2 | -35.76 Million USD | -16.25% |
| 2018 Q4 | -26.79 Million USD | 21.98% |
| 2018 Q1 | -27.76 Million USD | 0.0% |
| 2018 FY | -118.69 Million USD | -45.64% |
| 2018 Q2 | -27.76 Million USD | 0.0% |
| 2018 Q3 | -34.34 Million USD | -23.72% |
| 2017 FY | -81.49 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Absci Corporation | -115.51 Million USD | -492.395% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -201.409% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -142.511% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -6785.988% |
| Apollomics, Inc. | -54.83 Million USD | -1147.957% |
| 180 Life Sciences Corp. | -13.47 Million USD | -4977.388% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -2080.913% |
| Bicycle Therapeutics plc | -189.94 Million USD | -260.263% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -715.484% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -298.357% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2606.903% |
| Chimerix, Inc. | -93.06 Million USD | -635.298% |
| CRISPR Therapeutics AG | -222.53 Million USD | -207.5% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 4356.422% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -828.98% |
| Fortress Biotech, Inc. | -142.34 Million USD | -380.747% |
| Fortress Biotech, Inc. | -142.34 Million USD | -380.747% |
| Gritstone bio, Inc. | -154.63 Million USD | -342.532% |
| Allakos Inc. | -196.05 Million USD | -249.035% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -1148.823% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -463.237% |
| Cytokinetics, Incorporated | -496.2 Million USD | -37.908% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2525.883% |
| Innoviva, Inc. | 176.7 Million USD | 487.25% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -8796.041% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5695.726% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -438.56% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -5306671.493% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -567.237% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -670.041% |
| ImmuCell Corporation | -5.74 Million USD | -11804.936% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -409.046% |
| Incyte Corporation | 620.52 Million USD | 210.278% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -406.043% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -10372.952% |
| Mustang Bio, Inc. | -50.72 Million USD | -1249.022% |
| MiMedx Group, Inc. | 37.11 Million USD | 1943.693% |
| MEI Pharma, Inc. | 14.54 Million USD | 4805.714% |
| MacroGenics, Inc. | -168.24 Million USD | -306.734% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -7648.69% |
| Mereo BioPharma Group plc | -28.41 Million USD | -2308.168% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -4593.006% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -420.443% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -2062.238% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2859.851% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -4207.598% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -5579.351% |
| NextCure, Inc. | -67.63 Million USD | -911.732% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -1228.593% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -6378.321% |
| Onconetix, Inc. | -36.03 Million USD | -1799.022% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1540.468% |
| Opthea Limited | -191.84 Million USD | -256.701% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -1054.332% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -24767.315% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1489.735% |
| Precigen, Inc. | -88.92 Million USD | -669.548% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -2199.721% |
| Prime Medicine, Inc. | -191.29 Million USD | -257.728% |
| PureTech Health plc | -146.19 Million USD | -368.064% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -163.54% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 116.909% |
| Replimune Group, Inc. | -234.77 Million USD | -191.475% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -7804.95% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -3239.539% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -3423.982% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -40.461% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2715.304% |
| Sesen Bio, Inc. | -25.9 Million USD | -2541.186% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -149.742% |
| Solid Biosciences Inc. | -104.31 Million USD | -555.999% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -197.583% |
| SciSparc Ltd. | -5.77 Million USD | -11753.542% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -666.488% |
| TG Therapeutics, Inc. | 20.63 Million USD | 3416.556% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -478.058% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -9303.669% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -81.637% |
| UroGen Pharma Ltd. | -65.53 Million USD | -944.167% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -940.626% |
| XOMA Corporation | -41.84 Million USD | -1535.216% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -174.835% |
| AbCellera Biologics Inc. | -237.2 Million USD | -188.484% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -1105.633% |
| Cassava Sciences, Inc. | -105.95 Million USD | -545.833% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1418.07% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1464.626% |
| Dyadic International, Inc. | -8.22 Million USD | -8215.027% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -8125.808% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -57308.138% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -2238.865% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -421.602% |
| IGM Biosciences, Inc. | -263.46 Million USD | -159.737% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -536.433% |
| Acelyrin, Inc. | -422.06 Million USD | -62.133% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1351.798% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 5830.238% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -3306.232% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -775.014% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -430.518% |
| Senti Biosciences, Inc. | -92.72 Million USD | -637.978% |
| Mesoblast Limited | -58.79 Million USD | -1063.903% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -313.402% |
| ChromaDex Corporation | -5.59 Million USD | -12121.915% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -14181.746% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1379.386% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -8409.239% |
| Seer, Inc. | -103.46 Million USD | -561.401% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1454.885% |
| Novavax, Inc. | -566.51 Million USD | -20.793% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -4261.467% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -259.194% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1212.236% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -178.74% |
| Celcuity Inc. | -66.23 Million USD | -933.22% |
| ContextLogic Inc. | -328 Million USD | -108.63% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -308.999% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -600.458% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 218.273% |
| Amarin Corporation plc | -67.58 Million USD | -912.465% |
| AnaptysBio, Inc. | -164.41 Million USD | -316.216% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -2269.641% |
| Aptorum Group Limited | -10.52 Million USD | -6402.742% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -691.873% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -233.804% |
| Ardelyx, Inc. | -63.27 Million USD | -981.461% |
| Celularity Inc. | -192.28 Million USD | -255.877% |
| Omeros Corporation | -164.53 Million USD | -315.915% |
| Humacyte, Inc. | -100.04 Million USD | -583.984% |
| Immunocore Holdings plc | -59.64 Million USD | -1047.22% |
| IO Biotech, Inc. | -91.44 Million USD | -648.34% |
| GT Biopharma, Inc. | -13.57 Million USD | -4940.549% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -816.562% |
| Summit Therapeutics Inc. | -89.73 Million USD | -662.576% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1896.98% |
| Pulmatrix, Inc. | -14.74 Million USD | -4542.503% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -32.8% |
| Evogene Ltd. | -26.39 Million USD | -2492.948% |
| CorMedix Inc. | -48.95 Million USD | -1297.745% |
| BioLineRx Ltd. | -49.69 Million USD | -1277.037% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1972.333% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -2126.106% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -95.85% |
| scPharmaceuticals Inc. | -55.39 Million USD | -1135.297% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -518.363% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 737.856% |
| NLS Pharmaceutics AG | -11.8 Million USD | -5695.726% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2715.304% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -295.849% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -3087.855% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2561.837% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -496.225% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -723.938% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -1188.07% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -3521.103% |
| Daré Bioscience, Inc. | -30.83 Million USD | -2118.896% |
| bluebird bio, Inc. | -244.26 Million USD | -180.152% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 451.935% |
| DBV Technologies S.A. | -76.43 Million USD | -795.312% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -190.455% |
| Galecto, Inc. | -39.9 Million USD | -1614.835% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1746.279% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -1216.148% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -212.153% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1642.329% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -183.825% |
| ADMA Biologics, Inc. | 21.63 Million USD | 3263.392% |
| Clene Inc. | -40.54 Million USD | -1587.975% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -95.482% |
| Aptose Biosciences Inc. | -52.35 Million USD | -1207.023% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -4645.272% |
| Soligenix, Inc. | -7.69 Million USD | -8789.456% |
| Century Therapeutics, Inc. | -146.54 Million USD | -366.956% |
| Kura Oncology, Inc. | -165.8 Million USD | -312.719% |
| Surrozen, Inc. | -45.78 Million USD | -1394.768% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -632.206% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -27474.72% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -10453.748% |
| Autolus Therapeutics plc | -195.02 Million USD | -250.875% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -708.327% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -3137.781% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -489.618% |
| GRI Bio, Inc. | -11.38 Million USD | -5909.528% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -15053.857% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -837.674% |
| INmune Bio, Inc. | -29.74 Million USD | -2200.881% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -518.637% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1697.24% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -4182.43% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -8210.783% |
| Jaguar Health, Inc. | -34.29 Million USD | -1895.582% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -4239.056% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -1020.012% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2654.408% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -147.931% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -236.766% |
| Verastem, Inc. | -92.08 Million USD | -643.131% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -271.612% |
| Histogen Inc. | -10.64 Million USD | -6329.625% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -4322.872% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -832.562% |
| Surrozen, Inc. | -45.78 Million USD | -1394.768% |
| Organovo Holdings, Inc. | -15.08 Million USD | -4436.027% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -13343.483% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -8865.27% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -299.517% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1312.454% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -4395.862% |
| Kronos Bio, Inc. | -121.83 Million USD | -461.688% |
| Turnstone Biologics Corp. | -59.03 Million USD | -1059.21% |
| Synaptogenix, Inc. | -8.31 Million USD | -8130.9% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -4591.519% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -21541.524% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -646.316% |
| Exelixis, Inc. | 170.88 Million USD | 500.448% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -341.308% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -32.33% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -893.748% |
| ESSA Pharma Inc. | -32.13 Million USD | -2029.529% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -3896.396% |
| Avid Bioservices, Inc. | -18.67 Million USD | -3563.695% |
| Insmed Incorporated | -709.62 Million USD | 3.568% |
| MediWound Ltd. | -15.29 Million USD | -4375.507% |
| OmniAb, Inc. | -69.41 Million USD | -885.76% |
| Alector, Inc. | -151.74 Million USD | -350.972% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -533.715% |
| Zai Lab Limited | -366.57 Million USD | -86.676% |
| AlloVir, Inc. | -181.33 Million USD | -277.379% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -116.021% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -517.715% |
| Aura Biosciences, Inc. | -84.99 Million USD | -705.15% |
| Immunic, Inc. | -99.22 Million USD | -589.664% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -378.007% |
| Veracyte, Inc. | -85.79 Million USD | -697.605% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -142.821% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4715.658% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 888.261% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -9834.818% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -3541.35% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2588.504% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1863.582% |
| Fortrea Holdings Inc. | 63.1 Million USD | 1184.477% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -387.241% |
| XBiotech Inc. | -37.51 Million USD | -1724.327% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -893.748% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -302.672% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1707.032% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -919.525% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -534.168% |
| Agenus Inc. | -159.54 Million USD | -328.9% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2565.569% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -1184.067% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -20.221% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -771.815% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -559.832% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2975.095% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -392.196% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -12075.96% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2587.871% |
| Lantern Pharma Inc. | -17.87 Million USD | -3727.729% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1491.407% |
| Ainos, Inc. | -13.2 Million USD | -5081.618% |
| Pluri Inc. | -22.15 Million USD | -2988.298% |
| Prothena Corporation plc | -191.03 Million USD | -258.207% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -395.737% |
| Rallybio Corporation | -78.93 Million USD | -766.955% |
| Kodiak Sciences Inc. | -277.32 Million USD | -146.756% |
| Cue Biopharma, Inc. | -52.14 Million USD | -1212.211% |
| MeiraGTx Holdings plc | -137.06 Million USD | -399.27% |
| Annexon, Inc. | -143.72 Million USD | -376.128% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -958.542% |
| Moderna, Inc. | -4.23 Billion USD | 83.857% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -3587.187% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2695.021% |
| Blueprint Medicines Corporation | -486.27 Million USD | -40.723% |
| Immix Biopharma, Inc. | -16.14 Million USD | -4139.516% |
| CalciMedica, Inc. | -21.87 Million USD | -3028.251% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -377.496% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -299.489% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -906.39% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -109.332% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1814.408% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -913.02% |
| Nutriband Inc. | -4.87 Million USD | -13945.882% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1469.039% |
| Vor Biopharma Inc. | -126.03 Million USD | -442.944% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 116.132% |
| Alkermes plc | 414.12 Million USD | 265.242% |
| ProKidney Corp. | -151.52 Million USD | -351.621% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -960.363% |
| Arcellx, Inc. | -89.88 Million USD | -661.354% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | -12.667% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -499.358% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1697.397% |
| Atai Life Sciences N.V. | -125.47 Million USD | -445.389% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -738.205% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -740.577% |
| MediciNova, Inc. | -9.9 Million USD | -6811.987% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -441.496% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -9348.517% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2458.825% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -195.182% |
| Biomea Fusion, Inc. | -126.13 Million USD | -442.518% |
| RenovoRx, Inc. | -11.39 Million USD | -5904.782% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -258.108% |
| Geron Corporation | -193.94 Million USD | -252.836% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2380.534% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -506.293% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -182.581% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2615.927% |
| Royalty Pharma plc | 1.49 Billion USD | 145.86% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -229.002% |
| Imunon, Inc. | -21.03 Million USD | -3153.88% |
| BioAtla, Inc. | -129.68 Million USD | -427.659% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -108.797% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1538.74% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -300.279% |
| Structure Therapeutics Inc. | -102.77 Million USD | -565.828% |
| 89bio, Inc. | -151.2 Million USD | -352.571% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -550.251% |
| aTyr Pharma, Inc. | -54.91 Million USD | -1146.026% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -682.716% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -168.935% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -8232.222% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3971.79% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -7738254.388% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 302.713% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -298.431% |
| Liquidia Corporation | -73.38 Million USD | -832.499% |
| Entera Bio Ltd. | -8.89 Million USD | -7596.603% |
| GH Research PLC | -41.22 Million USD | -1560.048% |
| Vericel Corporation | -6.46 Million USD | -10486.402% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -776.157% |
| Xencor, Inc. | -138.63 Million USD | -393.588% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -13175.662% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -4182.43% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -3084.129% |
| Vaxcyte, Inc. | -468.04 Million USD | -46.206% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -219.688% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -4804.709% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -10372.952% |
| Portage Biotech Inc. | -18.25 Million USD | -3649.0% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -9348.517% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -551.961% |
| OncoCyte Corporation | -25.13 Million USD | -2622.41% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -5953.195% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -5872.78% |
| Purple Biotech Ltd. | 22.27 Million USD | 3172.628% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -2246.966% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -2235.113% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -271.185% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -9009.491% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -2209.423% |
| United Therapeutics Corporation | 1.18 Billion USD | 157.752% |
| HilleVax, Inc. | -133.34 Million USD | -413.184% |
| Silo Pharma, Inc. | -3.85 Million USD | -17648.377% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -17259.124% |
| Pharming Group N.V. | -4.87 Million USD | -13923.954% |
| Tharimmune, Inc. | -9.45 Million USD | -7137.325% |
| Genprex, Inc. | -31.07 Million USD | -2102.067% |
| Apogee Therapeutics, Inc. | -93 Million USD | -635.788% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -263.617% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -732.528% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -89351.634% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -12463.157% |
| OKYO Pharma Limited | -15.74 Thousand USD | -4344768.134% |
| Savara Inc. | -60 Million USD | -1040.375% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3801.619% |
| Curis, Inc. | -48.33 Million USD | -1315.843% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -13016.126% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -2411.211% |
| BeiGene, Ltd. | -1.2 Billion USD | 43.34% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -630.689% |
| Erasca, Inc. | -141.52 Million USD | -383.522% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -15016.168% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -15016.168% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1506.01% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -10659.513% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -917.751% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -342.795% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -228.787% |
| Adicet Bio, Inc. | -152.03 Million USD | -350.088% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -831.103% |
| Aditxt, Inc. | -26.06 Million USD | -2525.638% |
| Adagene Inc. | -23.71 Million USD | -2784.945% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9261.092% |
| Quantum-Si incorporated | -111.17 Million USD | -515.543% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -4594.169% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 660.841% |
| Compugen Ltd. | -12.99 Million USD | -5167.126% |
| Generation Bio Co. | -138.56 Million USD | -393.858% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -724.166% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -691.47% |
| Invivyd, Inc. | -207.78 Million USD | -229.336% |
| Relay Therapeutics, Inc. | -373 Million USD | -83.46% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -7196.526% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 3285.629% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -6552.134% |
| 2seventy bio, Inc. | -216.7 Million USD | -215.78% |
| Instil Bio, Inc. | -159.16 Million USD | -329.924% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2742.051% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -18550.629% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2458.825% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1762.966% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -559.876% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -301.875% |
| Evaxion Biotech A/S | -22.19 Million USD | -2982.872% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -730.649% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -206.693% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -755.97% |
| Cingulate Inc. | -22.75 Million USD | -2906.719% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 9233.809% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1432.015% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -1002.402% |
| Clearmind Medicine Inc. | -8.74 Million USD | -7728.367% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -798.085% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -23231.35% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -578.692% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -79.846% |
| ImmunityBio, Inc. | -362.25 Million USD | -88.904% |
| Korro Bio, Inc. | -84.53 Million USD | -709.503% |
| Kineta, Inc. | -15.72 Million USD | -4252.255% |
| BioVie Inc. | -32.17 Million USD | -2026.519% |
| Codexis, Inc. | -68.06 Million USD | -905.311% |
| Celularity Inc. | -192.28 Million USD | -255.877% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -4104.381% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -207.404% |
| Virax Biolabs Group Limited | -6.49 Million USD | -10433.485% |
| Cibus, Inc. | -318.88 Million USD | -114.594% |
| IN8bio, Inc. | -30.33 Million USD | -2155.678% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -452.791% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2818.892% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -93.454% |
| Eyenovia, Inc. | -25.4 Million USD | -2593.431% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 2196.523% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -12203.218% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1405.787% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -764.753% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1406.881% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -398.739% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -2099.701% |
| Moolec Science SA | -6.65 Million USD | -10184.416% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -1019.279% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1482.098% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -316.847% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1258.746% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -7236.137% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -3025.442% |
| Humacyte, Inc. | -100.04 Million USD | -583.984% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -753.972% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -4606.362% |
| Genelux Corporation | -24.16 Million USD | -2731.802% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1917.23% |
| Notable Labs, Ltd. | -14.65 Million USD | -4568.793% |
| Immunovant, Inc. | -282.7 Million USD | -142.053% |
| Quantum-Si incorporated | -111.17 Million USD | -515.543% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -3117.685% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -570.808% |
| Acasti Pharma Inc. | -11.31 Million USD | -5949.372% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2885.48% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1553.55% |
| PepGen Inc. | -84.76 Million USD | -707.287% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2888.623% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1985.78% |
| Immuneering Corporation | -58.41 Million USD | -1071.497% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -13343.483% |
| Belite Bio, Inc | -31.66 Million USD | -2060.872% |
| XOMA Corporation | -41.84 Million USD | -1535.216% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -913.485% |
| Bionomics Limited | -17.89 Billion USD | 96.175% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 2017.895% |
| uniQure N.V. | -282.87 Million USD | -141.914% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -9261.092% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -428.405% |
| Forte Biosciences, Inc. | -32.48 Million USD | -2006.461% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -8135.951% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -2227.964% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -12203.218% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -4715.658% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -7598.335% |
| Altimmune, Inc. | -95.92 Million USD | -613.345% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -835.994% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 2017.895% |
| Peak Bio, Inc. | -1356.23 USD | -50456312.26% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1279.536% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2942.708% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -182.417% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -2200.494% |
| Zura Bio Limited | -62.63 Million USD | -992.476% |
| PolyPid Ltd. | -22.86 Million USD | -2892.544% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -2200.494% |
| argenx SE | -425.04 Million USD | -60.994% |
| Immunome, Inc. | -109.53 Million USD | -524.765% |
| Verona Pharma plc | -67.83 Million USD | -908.84% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2525.883% |
| Shattuck Labs, Inc. | -91.95 Million USD | -644.158% |
| CervoMed Inc. | -7.81 Million USD | -8658.661% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -5037.039% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1320.486% |
| Moolec Science SA | -6.65 Million USD | -10184.416% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -4060.303% |
| Design Therapeutics, Inc. | -78.19 Million USD | -775.182% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -686.187% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1589.684% |
| Achilles Therapeutics plc | -75.25 Million USD | -809.315% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -23231.35% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -1134.116% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1246.103% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -935.273% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -1164.349% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1406.981% |
| Beam Therapeutics Inc. | -176.48 Million USD | -287.741% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -526.917% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1313.007% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -851.309% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -719.242% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -5336.646% |
| NeurAxis, Inc. | -6.66 Million USD | -10167.92% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -48.581% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1768.971% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 13371.213% |
| Palisade Bio, Inc. | -13.07 Million USD | -5135.692% |
| Nutriband Inc. | -4.87 Million USD | -13945.882% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -844.664% |
| Neurogene Inc. | -55.58 Million USD | -1131.141% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -7949.7% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -607.585% |
| Athira Pharma, Inc. | -125.46 Million USD | -445.411% |
| HCW Biologics Inc. | -25.71 Million USD | -2560.889% |
| XOMA Corporation | -41.84 Million USD | -1535.216% |
| Nektar Therapeutics | -137.42 Million USD | -397.948% |
| Arvinas, Inc. | -401.5 Million USD | -70.437% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -7738254.388% |
| Merus N.V. | -156.54 Million USD | -337.124% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -582.524% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1876.618% |
| Rezolute, Inc. | -70.42 Million USD | -871.707% |
| Clene Inc. | -40.54 Million USD | -1587.975% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -4078.075% |
| BeyondSpring Inc. | -23.11 Million USD | -2860.565% |
| Synlogic, Inc. | -55.16 Million USD | -1140.559% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3716.749% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -6222.108% |
| Peak Bio, Inc. | -1356.23 USD | -50456312.26% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1589.517% |
| Krystal Biotech, Inc. | -109.72 Million USD | -523.643% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -428.258% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -99.498% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -14318.706% |
| MannKind Corporation | 8.67 Million USD | 7985.515% |
| Ikena Oncology, Inc. | -75.41 Million USD | -807.362% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -6993.449% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -917.857% |
| Gossamer Bio, Inc. | -183.75 Million USD | -272.393% |
| CohBar, Inc. | -12.38 Million USD | -5423.802% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1249.075% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2380.534% |
| Legend Biotech Corporation | -439.48 Million USD | -55.706% |
| Mural Oncology plc | -194.63 Million USD | -251.578% |
| Disc Medicine, Inc. | -91.12 Million USD | -650.952% |
| Champions Oncology, Inc. | -7.35 Million USD | -9202.678% |
| REGENXBIO Inc. | -268.12 Million USD | -155.216% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -6284.522% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -1127.321% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1656.401% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -498.394% |
| Vaxart, Inc. | -83.34 Million USD | -721.031% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -7931.741% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1499.065% |
| Cellectis S.A. | -106.62 Million USD | -541.781% |
| Longeveron Inc. | -21.02 Million USD | -3154.101% |
| Repare Therapeutics Inc. | -116.22 Million USD | -488.781% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -155.505% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -804.627% |
| Revolution Medicines, Inc. | -487.18 Million USD | -40.461% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -10187.207% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1456.866% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -817.422% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -882.703% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -6114.74% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 115.886% |
| Denali Therapeutics Inc. | -196.69 Million USD | -247.894% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -7804.95% |
| Veru Inc. | -93.78 Million USD | -629.675% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2833.28% |
| Cingulate Inc. | -22.75 Million USD | -2906.719% |
| Passage Bio, Inc. | -108.38 Million USD | -531.342% |
| Context Therapeutics Inc. | -25.07 Million USD | -2629.292% |
| Exicure, Inc. | -14.99 Million USD | -4463.25% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -232.084% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1585.563% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -6942.394% |
| Nuvalent, Inc. | -149.49 Million USD | -357.754% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -8228.415% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -671.213% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -3194.045% |
| OmniAb, Inc. | -69.41 Million USD | -885.76% |
| Anew Medical, Inc. | -1.3 Million USD | -52504.855% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -5258.273% |
| Lipocine Inc. | -17.93 Million USD | -3716.333% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -898.796% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -798.604% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1697.24% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1631.234% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2957.117% |
| Sage Therapeutics, Inc. | -579.84 Million USD | -18.014% |
| Ocugen, Inc. | -65.53 Million USD | -944.246% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -629.023% |
| Q32 Bio Inc. | -92.1 Million USD | -642.986% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -3091.87% |
| Alumis Inc. Common Stock | -158.17 Million USD | -332.628% |
| Equillium, Inc. | -14.52 Million USD | -4612.195% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -996.537% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -8558.418% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -3527.358% |
| Dominari Holdings Inc. | -21.79 Million USD | -3039.59% |
| Edesa Biotech, Inc. | -9.22 Million USD | -7319.744% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2583.339% |
| Bio-Techne Corporation | 206.68 Million USD | 431.084% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -74.796% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 456.353% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -417.327% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1682.462% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -352.879% |
| Nkarta, Inc. | -131.65 Million USD | -419.791% |
| BioCardia, Inc. | -11.64 Million USD | -5776.889% |
| Iterum Therapeutics plc | -47.46 Million USD | -1341.613% |